Shanghai, China

Huijiao Li

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Oricell Therapeutics Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huijiao Li. Retrieved from https://idiyas.com/inventor/huijiao-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Huijiao Li: Innovator in Immune Cell Proliferation

Introduction

Huijiao Li is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunology, particularly in the area of immune cell proliferation. His innovative approach has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Huijiao Li holds a patent titled "Method for promoting proliferation of immune cells." This patent discloses a method that involves upregulating the expression of low-density lipoprotein receptor-related proteins or fragments thereof in immune cells. This advancement could lead to enhanced immune responses in clinical applications.

Career Highlights

Li is currently associated with Oricell Therapeutics Co., Ltd., where he continues to develop and refine his research. His work focuses on harnessing the body's immune system to improve health outcomes. With a patent portfolio that includes 1 patent, he is recognized for his innovative contributions to the field.

Collaborations

Some of Huijiao Li's notable coworkers include Hao Guo and Haili Ma. Their collaborative efforts contribute to the advancement of research and development in immunology.

Conclusion

Huijiao Li's work in promoting immune cell proliferation represents a significant step forward in immunological research. His innovative methods and collaborations are paving the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…